Charles Schwab Investment Management Inc. lifted its position in shares of Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free ...

Reports Q4 revenue $22.6M, consensus $4.28M. Revenue recognized for upfront license fees and services provided from the License and ...

Learn more about whether ACADIA Pharmaceuticals Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades, ...

The best way to experience the White Mountains’ Presidential Range is hiking between the Appalachian Mountain Club’s eight historic high-mountain huts. Connecting distances aren’t ridiculous—the ...

South Bow Corp. (TSX & NYSE: SOBO) (South Bow or the Company) reports its fourth-quarter and year-end 2024 financial and operational results and provides ...

Wasatch Long/Short Alpha Fund - Investor Class was down -8.28% and underperformed the benchmark Russell 2500™ Index, which ...

HAMMOND, La. ( KLFY) – Lafayette Christian Academy, top seed in Division III select, finds themselves in familiar territory, competing for a state championship. They have won the last 4 state titles.

ACAD reports mixed fourth-quarter results as earnings missed estimates while revenues beat the same, driven by year-over-year growth in Nuplazid and Daybue sales.

Acadia Pharmaceuticals ACAD reported fourth-quarter 2024 earnings of 17 cents ... Zacks Investment Research Research and development (R&D) expenses were $100.7 million, up 51% year over year.

Some healthcare analysts believe Neuren Pharmaceuticals (ASX:NEU) shares should be worth more than double their current soft ...

Trump is not the first American leader to dream of northern expansion. History suggests these designs reveal simmering divisions inside the United States.